A Statement from Dr. Brian O’Rourke, President and CEO
In November 2016 I represented CADTH at the two-day Opioid Summit, joining many others to discuss Canada’s response to the escalating opioid crisis and make a formal commitment to the Joint Statement of Action to Address the Opioid Crisis.
I…
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
See CDR Update 132 for important news and information regarding the CADTH Common Drug Review.
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
Dr. Irfan Dhalla
Vice-President of Evidence Development and Standards at Health Quality Ontario@IrfanDhalla
Health technology assessment and quality improvement have different historical and philosophical underpinnings, but people who use either approach share a common goal: better health care, and…
Ottawa, ON (November 8, 2017) — For Canadians living with end-stage kidney disease, undergoing dialysis at home should be considered as an alternative to regular visits to a dialysis centre, according to new evidence and expert recommendations from CADTH.
“The evidence tells us that in-centre and…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
On October 3, 2017, the Honourable Ginette Petitpas Taylor, Federal Minister of Health, announced a national external review of eight federally funded pan-Canadian health organizations (PCHOs), including CADTH. Dr. Danielle Martin and Dr. Pierre-Gerlier Forest have been appointed to co-lead the…
For many people living with end-stage kidney disease, dialysis is a life-long treatment. In Canada, dialysis is most often offered in a clinical setting and managed by a health care provider. However, several options for having dialysis at home without the assistance of a health care professional…